## Summary

This paper proposes an end-to-end framework for multi-view diabetic retinopathy (DR) grading that generates "lesion proposals" internally via a Grade-Activated Lesion Proposal (GALP) module (CAM-based region selection from auxiliary classifiers) and fuses them across views via a Cross-View Lesion Expert Guided Regional Fusion (LGRF) module (gated MoE with Top-K weighted cross-view attention). The claim is that self-generated proposals can substitute for expensive external lesion/vessel annotations. Experiments on MFIDDR (four-view) and DRTiD (two-view) datasets show competitive results: on DRTiD the method achieves the highest accuracy (76.0%) among all compared methods including those using external annotations.

## Strengths

- **Well-motivated problem.** The paper correctly identifies a genuine tension in the DR grading literature: methods using external lesion/vessel annotations perform better but are costly and create inference-time dependency. Reducing this dependency while preserving accuracy is a worthwhile goal (Section 1).
- **Architecturally clean and modular design.** The GALP module (auxiliary classifiers + CAM-based region selection) and LGRF module (gated MoE + Top-K weighted cross-view attention) are sensible, nontrivial, and well-explained. The two-module pipeline has clear design rationale (Sections 3.2–3.3).
- **Competitive empirical results on DRTiD.** On the two-view DRTiD dataset (Table 3), the proposed method achieves 76.0% overall accuracy, outperforming all baselines including externally informed methods (CVSA 74.7%, CrossFIT 75.6%). This is a clean win without any external annotations.
- **Useful hyperparameter analysis.** Figure 3 provides systematic exploration of retention ratio α, number of activated experts K₂, and total expert count M, showing clear performance peaks at α=0.5, K₂=2, M=6.

## Weaknesses

### Fatal
None.

### Major

- **Overclaimed "lesion proposal" framing without validation.** The paper's central narrative (title, Abstract, Sections 1, 3.2) claims GALP generates "lesion proposals" that act as surrogates for external annotations. What GALP actually produces are CAM-based grade-conditioned evidence maps (GEMs) — these highlight whatever spatial features are most discriminative for the predicted DR grade. The paper states that "regions with higher activation... are more likely to contain lesion evidence" (Section 3.2) as an assumption, not a demonstrated fact. CAMs trained on grade labels could equally highlight optic disc changes, vessel patterns, or dataset artifacts. The MFIDDR dataset *provides* lesion segmentation masks (Section 4.1), so the authors could have quantitatively validated whether proposals correspond to actual lesions (e.g., Dice overlap, visual overlays). They did not do this — no qualitative visualizations, no overlap analysis, no failure cases. The technical contribution (using CAM-selected grade-discriminative regions for cross-view attention) remains valid, but the framing substantially overstates what has been empirically shown.

- **Poor performance on Grade 4 (proliferative DR), the clinically most severe category.** On MFIDDR (Table 2), Ours (w/o lesion) achieves F1=36.0% on Grade 4 — among the lowest in the table. CVSA (with vessel) achieves F1=64.1%; SMVDR-W achieves 40.8%; MVCINN achieves 44.8%. Even Ours (with lesion) at F1=51.6% remains below CVSA. The paper's discussion of Table 2 focuses on Grade 3 improvements but does not adequately acknowledge this weakness. Claims of "superior robustness" and "elevat[ing] micro-lesion sensitivity" (Section 1) are contradicted by these results, and the paper's conclusions should be tempered accordingly.

### Minor

- **Missing backbone-controlled baseline.** The method uses Swin-B, while all compared end-to-end baselines (MVCINN, MVCNN.R, MVCNN.V, ETMC, RETFound) use different architectures (ViT variants, ResNet, VGG). Although the ablation (Table 4) keeps Swin-B constant when removing GALP/LGRF, there is no "plain Swin-B with simple multi-view aggregation" baseline. This makes it difficult to fully attribute the reported gains to the proposed modules versus the stronger backbone.

- **No statistical significance or variance reporting.** All results (Tables 1–4) are point estimates without confidence intervals or evidence of repeated runs. The margins over strong baselines are small (Ours w/o lesion is 0.3% below WGLIN, 0.1% below SMVDR-M). Without variance estimates, the reader cannot assess whether the claimed improvements are meaningful or due to random seed/split variation.

- **The "Ours (with lesion)" variant is under-described.** The paper states lesion segments are "fused with the original images via SPADE" (Section 4.1) but does not clarify whether this changes the backbone input (making it a fundamentally different pipeline) or whether lesion maps are also processed by GALP/LGRF. This limits interpretability of the with-lesion vs without-lesion comparison.

### Trivial
None.

## Nice-to-Haves

- Qualitative visualizations of the GEMs/Top-K proposals overlaid on fundus images would strengthen the paper's core claim.
- An ablation that isolates the gating mechanism (e.g., LGRF with uniform attention, no expert routing) would more precisely attribute the contribution of each component.
- Analysis of the load-balancing loss (Eq. 11) showing expert utilization histograms.

## Removed Points

These points are flagged to be removed, treat them with caution:

- **Criticism about "Lower model interpretability" claim in Figure 1 caption**: This is a standard comparison of two paradigms listed in a table, not an empirical claim by the paper. REMOVED.
- **Criticism about patch size divisibility**: The paper explicitly addresses this in Section 4.1 ("To ensure that the patch size exactly divides the spatial dimensions... we set the patch size to q=7 for MFIDDR and q=8 for DRTiD"). REMOVED (misread by reviewer).
- **Criticism about cyclic adjacency scheme not being justified/ablated**: This is a design choice, not a claimed optimality. REMOVED.
- **Criticism about not reporting focal loss hyperparameters**: Minor implementation detail. REMOVED.
- **Criticism about load-balancing loss effect not analyzed**: Nice-to-have, not a core weakness. REMOVED.
- **Generic scope-creep criticisms** (broader evaluation, more datasets, etc.): REMOVED as per filtering rules.

## Novel Insights

The most incisive observation from the review process is the gap between the paper's "lesion proposal" framing and what the method actually demonstrates. The paper asserts that CAM-selected regions correspond to lesions, but this is an untested assumption despite the availability of lesion segmentation masks on MFIDDR. This gap is not fatal to the technical contribution (the MoE-based cross-view fusion with grade-discriminative region selection is a legitimate contribution regardless of whether those regions are "lesions"), but it means the paper's narrative substantially overstates its evidentiary support. The remaining insights (missing backbone baseline, poor Grade 4 performance, no variance reporting) are standard evaluation critiques that collectively weaken but do not invalidate the paper.

## Suggestions

1. Validate the lesion-proposal claim by computing overlap metrics (Dice/Precision/Recall) between GALP proposals and available lesion masks on MFIDDR, with qualitative visual overlays.
2. Add a plain Swin-B baseline (Swin-B with simple multi-view aggregation, no GALP/LGRF) to Tables 1 and 4.
3. Report results with confidence intervals or standard deviations over multiple runs.
4. Acknowledge and discuss the Grade 4 weakness explicitly.
5. Clarify how the "Ours (with lesion)" variant integrates lesion maps via SPADE.
6. Tone down the "lesion proposal" framing unless validated, or replace with more precise terminology (e.g., "grade-discriminative region proposals").

---

## Calibration Report

### Round 1 — Bracketing

Initial bracket determined as [4, 6] after comparing against medical-image calibration anchors.

### Round 2 — Narrowing

Searched within [4.5, 6.5] and [3.0, 5.0] bands for more focused comparison.

### Anchors Retrieved (all rounds)

| Path | Avg Score | Round | Itemized | Comparison |
|------|-----------|-------|----------|------------|
| `QQBPWtvtcn.md` (LVSM) | 7.67 | R1 | No | 3D view synthesis; not topically comparable |
| `TPZRq4FALB.md` (READ) | 8.00 | R1 | No | Multi-modal TTA; stronger theoretical grounding |
| `FUgrjq2pbB.md` (MVDream) | 6.50 | R1 | No | Multi-view diffusion; different subfield |
| `iGbuc9ekKK.md` (Duoduo CLIP) | 5.75 | R1 | No | 3D understanding; different subfield |
| `s4MwstmB8o.md` (MVP) | 6.25 | R1 | No | Multi-view VAE; comparable score band |
| `h9TTpQdGKJ.md` (MAVRL) | 4.25 | R1 | Yes | Few-shot robustness; lower quality than this paper |
| `8g5Ye3c3oR.md` (CoinGAN) | 4.50 | R1, R2, R3 | Yes | Weakly supervised lesion segmentation; closest topical match. Had severe presentation issues (negatively-weighted weaknesses) that this paper lacks. |
| `NJxCpMt0sf.md` (M4oE) | 5.75 | R2, R3 | Yes | Multi-modal MoE for medical diagnosis. Accepted; shares missing-significance weakness but has more extensive evaluation. |
| `Naiy1jf8UA.md` (MGDC-UNet) | 6.00 | R2 | Yes | Medical image segmentation. Had novelty concerns (*5.24 weight) that this paper lacks. |
| `QG31By6S6w.md` (Malenia) | 6.25 | R3 | No | Zero-shot lesion segmentation; accepted, stronger validation |
| `2wkjYEYoss.md` (Gamma) | 5.25 | R3 | Yes | Mixture of experts for image assessment. Rejected; had unfair comparison concerns. |

### Weighted-Item Comparison

This paper's strengths (weights 8.57–11.16) are stronger than CoinGAN (4.50) and comparable to M4oE (5.75). Its weaknesses lack the severely negative weights seen in CoinGAN (-2.20, -1.93) and MGDC-UNet (-5.24). However, the two Major weaknesses (unvalidated lesion framing weight 2.62; Grade 4 performance weight 2.31) are substantive, and the paper lacks the heavier-weight positive items (e.g., extensive cross-dataset validation) that lifted M4oE to 5.75. The paper sits closest to Gamma (5.25, rejected) in overall profile — genuine architectural contribution undermined by an overclaimed central narrative and incomplete evaluation.

### Final Score Determination

The paper has two Major weaknesses (overclaimed framing without validation, poor Grade 4 performance) that together prevent acceptance. The DRTiD results and architectural novelty are genuine strengths, but the central claim requires either validation or reframing. This profile is most consistent with the 5.0 band — borderline reject with clear potential after revision.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>